Protective effect of caffeine administration on myocardial ischemia/reperfusion injury in rats

Shock

Volumn 36, Issue 3, 2011, Pages 289-294

  Li, Xu Yong ^a,b   Xu, Lin ^a,b   Lin, Guo Sheng ^a,b   Li, Xiao Yan ^a,b   Jiang, Xue Jun ^a,b   Wang, Tao ^a,b   Lü, Jing Jun ^a,b   Zeng, Bin ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

apoptosis; Inflammation; iNOS; NF B; PARP

Indexed keywords

CAFFEINE; CASPASE 3; CREATINE KINASE; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; INFLAMMATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; REPERFUSION INJURY; SHAM PROCEDURE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CAFFEINE; CASPASE 3; CREATINE KINASE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HYDRO-LYASES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MALE; MYOCARDIAL REPERFUSION INJURY; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RANDOM ALLOCATION; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052029327     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182222915     Document Type: Article

References (23)

1. Cannon RO 3rd: Mechanisms, management and future directions for reperfusion injury after acute myocardial infarction. Nat Clin Pract Cardiovasc Med 2(2):88-94, 2005.
2. Bolli R, Becker L, Gross G, Mentzer R Jr, Balshaw D, Lathrop DA: Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ Res 95(2):125-134, 2004. (Pubitemid 38988678)
3. Sarris A: Medium-Term Prospects for Agricultural Commodities. Projections to the Year 2010. Rome, Italy: FAO: 67, 2003.
4. de Koning Gans JM, Uiterwaal CS, van der Schouw YT, Boer JM, Grobbee DE, Verschuren WM, Beulens JW: Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler Thromb Vasc Biol 30(8):1665-1671, 2010.
5. Virag L, Szabo C: The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54(3):375-429, 2002.
6. Geraets L, Moonen HJ, Wouters EF, Bast A, Hageman GJ: Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations. Biochem Pharmacol 72(7):902-910, 2006. (Pubitemid 44301052)
7. Barone JJ, Roberts HR: Caffeine consumption. Food Chem Toxicol 34(1):119-129, 1996. (Pubitemid 26057854)
8. Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. Rockville, Md: Federal Drug Administration, 2005. p. 7.
9. Mullane KM, Kraemer R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14(3):157-167, 1985. (Pubitemid 15241170)
10. Liaudet L, Szabo E, Timashpolsky L, Virag L, Cziraki A, Szabo C: Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br J Pharmacol 133(8):1424-1430, 2001. (Pubitemid 32783505)
11. Ferrari R: Importance of oxygen free radicals during ischemia and reperfusion in the experimental and clinical setting. Oxygen free radicals and the heart. Am J Cardiovasc Pathol 4(2):103-114, 1992.
12. Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, Lopez BL, KochW, Chan L, Goldstein BJ, et al.: Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115(11):1408-1416, 2007. (Pubitemid 46648376)
13. Freude B, Masters TN, Robicsek F, Fokin A, Kostin S, Zimmermann R, Ullmann C, Lorenz-Meyer S, Schaper J: Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol 32(2):197-208, 2000. (Pubitemid 30670343)
14. Ye Y, Abu Said GH, Lin Y, Manickavasagam S, Hughes MG, McAdoo DJ, Perez-Polo RJ, Birnbaum Y: Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat. Cardiovasc Drugs Ther 22(4):275-282, 2008.
15. Bonita JS, Mandarano M, Shuta D, Vinson J: Coffee and cardiovascular disease: in vitro, cellular, animal, and human studies. Pharmacol Res 55(3):187-198, 2007. (Pubitemid 46518151)
16. Headrick JP, Lasley RD: Adenosine receptors and reperfusion injury of the heart. Handb Exp Pharmacol 193:189-214, 2009.
17. Ikeda U, Ikeda M, Kano S, Shimada K: Neutrophil adherence to rat cardiac myocyte by proinflammatory cytokines. J Cardiovasc Pharmacol 23(4):647-652, 1994. (Pubitemid 24100152)
18. Lopez-Garcia E, van Dam RM, Qi L, Hu FB: Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84(4):888-893, 2006. (Pubitemid 44715672)
19. Yang Z, Zingarelli B, Szabo C: Effect of genetic disruption of poly (ADPribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. Shock 13(1):60-66, 2000.
20. Morrow DA, Brickman CM, Murphy SA, Baran K, Krakover R, Dauerman H, Kumar S, Slomowitz N, Grip L, McCabe CH, et al.: A randomized, placebocontrolled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial. J Thromb Thrombolysis 27(4):359-364, 2009.
21. Olszanecki R, Gebska A, Jawien J, Jakubowski A, Korbut R: Inhibition of NOS-2 induction in LPS-stimulated J774.2 cells by 1, 5-isoquinolinediol, an inhibitor of PARP. J Physiol Pharmacol 57(1):109-117, 2006.
22. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G: Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18(16):4446-4454, 1999. (Pubitemid 29391254)
23. Eefting F, Rensing B, Wigman J, Pannekoek WJ, Liu WM, Cramer MJ, Lips DJ, Doevendans PA: Role of apoptosis in reperfusion injury. Cardiovasc Res 61(3): 414-426, 2004. (Pubitemid 38210148)